Noveris Health Sciences Inc., a biotechnology company, engages in the research, development, and commercialization of psilocybin products to treat mental health conditions. The company primarily focuses on treating nicotine addiction and po…
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Results 2026-05-28
Interim MD&A - English.pdf
Results 2026-05-28
Interim financial statements/report – English.pdf
Ownership 2026-05-20
Bartch, David Joshua sold +$4.6M
Insider trading – 2026-05-20
1 insider · −$4.6M net
Results 2026-05-01
Annual MD&A - English.pdf
Results 2026-05-01
Audited annual financial statements – English.pdf
Transactions 2026-04-29 M&A
NOVERIS HEALTH SCIENCES PROVIDES CORPORATE UPDATE, AND ANNOUNCES AGREEMENT FOR ACQUISITION OF STEM CELL DISTRIBUTION BUSINESS
News release - English.pdf
News 2026-04-22
NOVERIS HEALTH SCIENCES INC. ANNOUNCES SIGNING OF MARKET MAKING ADVISORY AGREEMENT WITH DS MARKET SOLUTIONS INC.
News release - English.pdf
News 2026-04-20
Noveris Health Sciences Inc. Provides Clarifying News Release Regarding Life Offering and Other Disclosure
News release - English.pdf
Transactions 2026-03-30 Financing
Report of exempt distribution (45-106F1).pdf
Transactions 2026-03-23 Financing
Noveris Health Sciences Inc. Closes Non-Brokered Private Placement
Material change report - English.pdf
News 2026-03-23
Early warning report.pdf
Transactions 2026-03-19 Financing
NOVERIS ANNOUNCES CLOSING OF LIFE OFFERING
News release - English.pdf
News 2026-03-14
Noveris Health Sciences Launches Investor Website and Engages Fairfax Partners Inc. for Investor Relations and Digital Marketing Services
News release - English.pdf
News 2026-03-12
Offering document - English.pdf
Transactions 2026-03-12 Financing
NOVERIS ANNOUNCES LIFE OFFERING
News release - English.pdf
Ownership 2026-03-07
NOVERIS ANNOUNCES CONVERSION OF DEBENTURES; FILING OF EARLY WARNING REPORTS BY JJK HOLDINGS LTD. AND JOSHUA BARTCH
News release - English.pdf
News 2026-02-28
Early warning report.pdf
News 2026-02-27
Early warning report.pdf
Ownership 2026-02-27
JJK HOLDINGS LTD. ACQUIRES $7,878,792 CONVERTIBLE DEBENTURE OF NOVERIS HEALTH SCIENCES INC.; FILING OF EARLY WARNING REPORTS BY JJK HOLDINGS LTD. AND PIONEER GARAGE LIMITED
News release - English.pdf
Transactions 2026-02-18 Financing
Noveris Health Sciences Inc. Provides Supplemental Disclosure Regarding Previously Announced Convertible Debenture Issuances
News release - English.pdf
News 2026-02-06
Notice.pdf
Transactions 2026-02-06 M&A
Noveris Health Sciences Inc. announces name change from Mydecine Innovation Group Inc.
Material change report - English.pdf
News 2026-02-02
Certificate and articles of change of name.pdf
News 2025-11-26
Early warning report.pdf
Ownership 2025-11-26
EARLY WARNING NEWS RELEASE REGARDING DEBT SETTLEMENT BY RAY VAN EMPEL IN MYDECINE INNOVATIONS GROUP INC.
Press release - English.pdf
Results 2025-11-17 Financials
Interim MD&A - English.pdf
Results 2025-11-17 Financials
Interim financial statements/report – English.pdf
News 2025-10-22
Report of exempt distribution (45-106F1).pdf
News 2025-10-22
Material change report - English.pdf
News 2025-10-21
Other securityholders documents - English.pdf
News 2025-10-21
Cover letter.pdf
News 2025-10-21
Other.pdf
News 2025-10-21
Other securityholders documents - English.pdf
News 2025-10-21
Other securityholders documents - English.pdf
News 2025-10-21
Other securityholders documents - English.pdf
News 2025-10-21
Material change report - English.pdf
News 2025-10-17
Early warning report.pdf
News 2025-10-17
Press release - English.pdf
News 2025-10-14
News release - English.pdf
News 2025-10-06
News release - English.pdf
News 2025-08-29
Other.pdf
News 2025-08-29
Other.pdf
News 2025-08-29
Other.pdf
News 2025-08-12
Statement of executive compensation (form 51-102F6V) - English.pdf
Results 2025-07-22 Financials
Interim MD&A - English.pdf
Results 2025-07-22 Financials
Interim financial statements/report – English.pdf
Results 2025-07-09 Financials
Interim MD&A - English.pdf
Results 2025-07-09 Financials
Interim financial statements/report – English.pdf
Results 2025-07-02 Financials
Annual MD&A - English.pdf
Results 2025-07-02 Financials
Audited annual financial statements – English.pdf
News 2025-06-26
News release - English.pdf
News 2025-06-12
News release - English.pdf